KRAS and adenocarcinoma: When only pathological mutations at an AF of >20% were examined, common mutations were detected in genes encoding TP53, KRAS, and EGFR in adenocarcinoma and in the TP53 gene in squamous cell carcinoma (Figure 2A,B).